|
1. Fung ET, Wilson AM, Zhang F, et al. A biomarker panel for peripheral arterial disease. A biomarker panel for peripheral arterial disease. Vasc Med Aug;13(3):217-24.2008.
2. Huang PH, Lu TM, Wu TC, et al. Usefulness of combined high-sensitive C-reactive protein and NT-pro BNP for predicting cardiovascular events in patients with suspected coronary artery disease. Coron Artery Dis 19:187-93. 2008.
3. Anderson JL. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention. Am J Cardiol 16;101(12A):23F-33F,2008
4. Davidson MH, Corson MA, Alberts MJ, et al. Consensus panel recommendation for incorporating LpA-A2 testing into cardiovascular disease risk assessment guidelines. Am J Cardiol 101(12A):51F-57F,2008
5. Eggers KM, Lagerqvist B, Oldgren J, et al. Pathophysiologic mechanisms of persistent cTnI elevation in stabilized patients after an episode of ACS. Am Heart J 156(3):588-94, 2008.
6. Dai DF, Hwang JJ, Lin JL, et al. Joint effects of NT-pro BNP and C-reactive protein vs. angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease. Circ J 2008 Aug;72(8):1316-23
7. Nienhuis MB, Ottervanger JP, Dikkeschei B, et al. Prognostic importance of cTnT and CK after elective angioplasty. Int J Cardiol 120(2):242-7, 2007.
8. Saadeddin SM, Habbab MA, Sobki SH, Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: detection by cardiac troponins. Ann Clin Biochem 392-7, 2002.
9. Nienhuis MB, Ottervanger JP, Bilo HJ. Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis. Catheter Cardiovasc Interv 2008 Feb 15;71(3):325-6.
10. Jeremias A, Kleiman NS, Nassif D, et al Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Circulation 118(6):632-8, 2008.
11. Sabatine MS, Morrow DA, Higgins LJ,et al.Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 117(15):1936-44, 2008.
|